Stocks News

LAST PRICE
340.7450
TODAY'S CHANGE (%)
Trending Down-2.0150 (-0.5879%)

Bid / Lots
340.6000/ 2
Ask / Lots
340.8900/ 2
Open / Previous Close
342.2400 / 342.7600
Day Range
Low 339.9000
High 343.2000
52 Week Range
Low 310.4200
High 415.7300
Volume
113,732
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 9, 2024
- West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing, from 3:43PM ET on Thursday May 09, 2024 by MT Newswires
  3:43PM ET on Thursday May 09, 2024 by MT Newswires
  Companies Mentioned: WST
  03:43 PM EDT, 05/09/2024 (MT Newswires) -- Eric Mark Green, Director, President, CEO and Board Chair, on May 07, 2024, sold 66,000 shares in West Pharmaceutical Services (WST) for $24,199,050. Following the Form 4 filing with the SEC, Green has cont...
Apr 30, 2024
- West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire
  Companies Mentioned: WST
  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
- West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  Companies Mentioned: WST
  
  West to Participate in Upcoming Investor Conference
  
  PR Newswire
  
  EXTON, Pa., April 30, 2024
  
  EXTON, Pa., April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
Apr 26, 2024
- UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  11:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  11:34 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average rating of outperform and price targets ranging from $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and eco...
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  10:56AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: WST
  10:56 AM EDT, 04/26/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic ...

Today
- Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target, from 3 hours ago by MT Newswires
  3 hours ago by MT Newswires
  Companies Mentioned: ZBH
Yesterday
- Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing, from 19 hours ago by MT Newswires
  19 hours ago by MT Newswires
  Companies Mentioned: STE
May 17, 2024
- Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing, from 4:37PM ET on Friday May 17, 2024 by MT Newswires
  4:37PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: STE
- Steris Insider Sold Shares Worth $475,300, According to a Recent SEC Filing, from 4:36PM ET on Friday May 17, 2024 by MT Newswires
  4:36PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: STE
May 16, 2024
- Steris Insider Sold Shares Worth $707,850, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires
  4:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: STE
- Steris Insider Sold Shares Worth $476,093, According to a Recent SEC Filing, from 4:37PM ET on Thursday May 16, 2024 by MT Newswires
  4:37PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: STE
May 13, 2024
- Align Technology to Speak at Upcoming Financial Conferences, from 1:53PM ET on Monday May 13, 2024 by Business Wire
  1:53PM ET on Monday May 13, 2024 by Business Wire
  Companies Mentioned: ALGN
May 10, 2024
- Wolfe Research Adjusts Price Target on STERIS to $240 From $235, from 8:05AM ET on Friday May 10, 2024 by MT Newswires
  8:05AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: STE
- Piper Sandler Adjusts Price Target on STERIS to $225 From $220, from 7:16AM ET on Friday May 10, 2024 by MT Newswires
  7:16AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: STE
- KeyBanc Adjusts Price Target on STERIS to $255 From $253, from 6:07AM ET on Friday May 10, 2024 by MT Newswires
  6:07AM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: STE

West Pharmaceutical Services Inc
NYSE:WSTUnited States

Search Criteria

May 9, 2024

West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing, from 3:43PM ET on Thursday May 09, 2024 by MT Newswires

Apr 30, 2024

West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by PR Newswire

West to Participate in Upcoming Investor Conference, from 6:00AM ET on Tuesday Apr 30, 2024 by Dow Jones

Apr 26, 2024

UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating, from 11:34AM ET on Friday Apr 26, 2024 by MT Newswires

Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423, from 10:56AM ET on Friday Apr 26, 2024 by MT Newswires

Peers Headlines

Today

Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target, from 3 hours ago by MT Newswires

Yesterday

Steris Insider Sold Shares Worth $267,313, According to a Recent SEC Filing, from 19 hours ago by MT Newswires

May 17, 2024

Steris Insider Sold Shares Worth $7,532,366, According to a Recent SEC Filing, from 4:37PM ET on Friday May 17, 2024 by MT Newswires

Steris Insider Sold Shares Worth $475,300, According to a Recent SEC Filing, from 4:36PM ET on Friday May 17, 2024 by MT Newswires

May 16, 2024

Steris Insider Sold Shares Worth $707,850, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires

Steris Insider Sold Shares Worth $476,093, According to a Recent SEC Filing, from 4:37PM ET on Thursday May 16, 2024 by MT Newswires

May 13, 2024

Align Technology to Speak at Upcoming Financial Conferences, from 1:53PM ET on Monday May 13, 2024 by Business Wire

May 10, 2024

Wolfe Research Adjusts Price Target on STERIS to $240 From $235, from 8:05AM ET on Friday May 10, 2024 by MT Newswires

Piper Sandler Adjusts Price Target on STERIS to $225 From $220, from 7:16AM ET on Friday May 10, 2024 by MT Newswires

KeyBanc Adjusts Price Target on STERIS to $255 From $253, from 6:07AM ET on Friday May 10, 2024 by MT Newswires